Cosmos Health’s strategy goes beyond mere crypto investment. Unlike companies casually adding Ethereum (ETH) to their asset portfolio for hedging purposes or publicity, Cosmos Health is building its future business model upon Ethereum. The organization is fully integrating Ethereum’s technology into supply chain improvements, digital transformation, and customer interaction strategies.

The structure of the funding agreement is noteworthy; approximately 72.5% of the capital raised in each financial round will be directly funneled into acquiring ETH. This ensures a consistent inflow of funds into the Ethereum ecosystem. Furthermore, this ETH will be staked through BitGo, which aims to decrease the amount of ETH in circulation and enhance network security.

Widespread adoption of treasury-based ETH accumulation across diverse sectors could establish enduring support for the asset’s value.
According to insights from analysts, including Standard Chartered’s Geoffrey Kendrick, firms centered around Ethereum treasuries potentially yield superior results compared to those heavily invested in Bitcoin, owing to the enhanced DeFi access and staking rewards available. This development is seen as favorable for Ethereum’s medium-to-long-term value.
Following a wave of Bitcoin treasury announcements earlier in 2025, several organizations are starting to implement strategies focused around Ethereum as a treasury asset.

Ethereum Price Stabilizes Around $3,600

ETH/USD Daily Chart-

TradingView

From a technical perspective, Ethereum is currently trading at $3,692, having rebounded from the lower Bollinger Band near the $3,460 mark. The chart shows a period of price consolidation after a strong upward movement throughout July. The price is now trending upward towards the median Bollinger Band, with the upper band situated at roughly $3,890, acting as a minor resistance point.

The Heikin Ashi candles are shifting back to green, potentially signaling a weakening of the recent downward trend. Should this positive bounce continue and ETH close above the $3,715 threshold, momentum could strengthen, propelling the price toward the $4,000 level once more. Further upward movement above this level could see the price testing targets near $4,400 and possibly $4,800, based on Fibonacci extension levels.

Should buyers fail to maintain upward pressure, and ETH decline below $3,460, a retest of the $3,200 support level might occur. However, the new signal of institutional demand from Cosmos Health strengthens the incentive to buy on price dips.

Will Cosmos Health’s Investment Spark an ETH Price Surge?

It’s not guaranteed, but news like this is closely monitored by institutional investors. A company listed on the Nasdaq allocating nine figures to Ethereum sends a strong signal and could encourage other corporations to do the same. This may create a positive shock to demand and reduce circulating supply, particularly given the staking component involved.

This, combined with the technical indicators—a price bounce at a crucial support level, narrowing Bollinger Bands, and decreasing selling pressure—suggests conditions that are potentially favorable for a breakout. The only remaining factor is confirmation through increased trading volume.

Ethereum Price Trajectory: Anticipating Future Movements

If momentum persists, and the ETH price surpasses $3,715 on a daily closing basis, a potential advance towards $4,000 and higher may unfold. A sustained upward surge could pave the way for targets at $4,400 and $4,800, as indicated by Fibonacci projections. Conversely, $3,460 remains a vital level to observe on the downside. A breach below this level might lead to a test of $3,200 but could attract significant buying activity, influenced by the current bullish environment.

In the short term, the $3,715 resistance level remains the primary focus. If this level is broken, the Cosmos Health announcement could be the catalyst needed to ignite a significant rally in Ethereum’s price.

📈
Check $Ethereum’s Real-Time Price

📊
Compare Top Crypto Exchanges

Share.